Corriente Advisors as of June 30, 2020
Portfolio Holdings for Corriente Advisors
Corriente Advisors holds 16 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Maxar Technologies | 22.1 | $34M | 1.9M | 17.96 | |
| Reata Pharmaceuticals Cl A | 14.9 | $23M | 148k | 156.02 | |
| Sonos (SONO) | 14.9 | $23M | 1.6M | 14.63 | |
| Aptose Biosciences Com New | 11.3 | $18M | 2.8M | 6.31 | |
| Cue Biopharma (CUE) | 10.5 | $16M | 660k | 24.51 | |
| Replimune Group (REPL) | 7.8 | $12M | 485k | 24.85 | |
| Uniqure Nv SHS (QURE) | 5.3 | $8.1M | 180k | 45.06 | |
| Ocular Therapeutix (OCUL) | 3.9 | $6.0M | 720k | 8.33 | |
| Celldex Therapeutics Com New (CLDX) | 3.9 | $6.0M | 460k | 13.00 | |
| Tesla Motors (TSLA) | 1.4 | $2.2M | 2.0k | 1080.00 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.1 | $1.7M | 40k | 43.20 | |
| Diamedica Therapeutics Com New (DMAC) | 0.9 | $1.4M | 201k | 6.93 | |
| Pan American Silver Corp Can (PAAS) | 0.6 | $912k | 30k | 30.40 | |
| Cardiff Oncology (CRDF) | 0.6 | $869k | 173k | 5.01 | |
| Pieris Pharmaceuticals | 0.5 | $837k | 270k | 3.10 | |
| Redwood Trust (RWT) | 0.3 | $525k | 75k | 7.00 |
